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GLOSSARY  
BMI    - Body Mass index 
BP   - Blood Pressure 
CAD   - Coronary Artery Disease  
CHD   - Coronary Heart Disease  
CM   - Chylomicrone  
CRP   - C Reactive Protein  
CVA   - Cerebro Vascular Accidents  
CVD   - Cardio Vascular disease  
DM   - Diabetes Mellitus  
DBP   - Diastolic Blood Pressure  
ECG   -  Electro Cardiogram.    
EF   - Ejection Fraction  
F/H   - Family History  
HT   - Hypertension  
HDL   - High Density Lipoprotein  
HC   - Hip Circumference  
IR   - Insulin Resistance  
LDL   - Low Density Lipoprotein  
Lp (a)   - Lipoprotein (a) 
MI   - Myocardial infarction 
MS   - Metabolic Syndrome  
NCEP – ATP III - National Cholesterol Education programme.  
Adult Treatment Panel - III     
 IDF   - International Diabetic Federation   
 OCP   - Oral Contraceptive Pill 
 PI   - Physical Inactivity  
 SBP   - Systolic Blood Pressure  
 TC   - Total Cholesterol 
 TG   - Triglyceride  
 VLDL  - Very Low Density Lipoproteins  
 WC   - Waist Circumference 
 WHO   - World Health Organisation  
 WHR   - Waist Hip Ratio  
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INTRODUCTION 
 
 In today’s world, most of the deaths are attributable to non-
communicable diseases and just over half of these are as a result of 
cardiovascular disease.  
 Coronary artery disease is projected to become the leading cause of 
global morbidity and mortality by 2020.  WHO has drawn attention to the 
fact that CAD is our modern “epidemic”. When emerged as the modern 
epidemic, it was the disease of the higher social classes. Fifty years later 
the situation is changing, there is a strong inverse relationship between 
social class and CAD in developed countries.  
 This trend has grave implications for countries in South Asia. Even 
with low socioeconomic status, rates of CAD are higher in south Asians 
and some studies shows that CAD rates in India parallel those in the 
developed countries. In Indians CAD appears a decade earlier compared 
with the age incidence in developed countries.  
 The present mortality rates are the consequences of previous 
exposure to behavioural risk factors such as inappropriate nutrition, 
insufficient physical activity and increased tobacco consumption. 
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Overweight, central obesity, high blood pressure, dyslipidemia, diabetes 
and low cardiorespiratory fitness are the important contributing factors.  
 The metabolic syndrome refers to a specific clustering of cardio 
vascular risk factors in the same individual. Persons with this syndrome 
have a greater risk of death from CAD. So the diagnosis of this syndrome 
provides early identification of individuals with high risk for CAD and 
therefore an opportunity to intervene at an earlier stage.  
 Waist circumference appears to be the most predictive ‘screening 
factor’ among the metabolic syndrome criteria. Patient with normal body 
mass index may still have elevated waist circumference and increased 
central adiposity.  
 This study tries to bring out the significance of waist circumference 
for detecting people with high cardiovascular risk and to determine the 
optimum level of waist circumference, body mass index and waist hip 
ratio for diagnosing central obesity in our population. 
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REVIEW OF LITERATURE  
 
 
Evolution of cardiometabolic risk factor clustering as a ‘syndrome’ 
 The propensity for clustering of metabolic and cardiovascular risk 
factors in the same individual has been recognised for many years. 
Perhaps the first description of cardiometabolic risk factor clustering 
appeared in the medical literature in 1923 when Eskil Kylin (1889 – 
1975), a sweedish physician, described a syndrome involving 
hypertension, hyperglycemia, and hyperuricemia1. Sixty five years later in 
1998, Reaven described a cluster of risk factors for  diabetes and CVD. 
(hypertension, hyperglycemia, glucose intolerance, elevated triglycerides  
and low HDL level). He named it as syndrome X’ and introduced the 
concept of insulin resistance. In 1998 WHO proposed the term metabolic 
syndrome rather than insulin resistance syndrome, since insulin resistance 
alone could not explain all components of the syndrome. However use of 
the term ‘metabolic syndrome’ remained relatively uncommon until 2001 
when the National cholesterol education program Adult treatment panel 
(NCEP ATP III) identified the metabolic syndrome as a risk factor for 
CVD and as a target for lipid – modifying and other CVD risk reduction 
therapies. 
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CORONARY ARTERY DISEASE 
 
 Coronary artery disease is the leading cause of death all over the 
world. CAD rate vary 10 fold among populations. CAD rates among 
overseas Asian Indians world wide are 50% to 400% higher than people 
of other ethnic origin irrespective of gender, religion and cast. 
 India is now in the middle of a CAD epidemic with urban Indians 
having CAD rates which is 4 fold higher than Americans (Enas Enas et 
al)2. 
Cardinal features of CAD among Asian Indians: 
 Asian Indians are prone to develop CAD at a younger age, often 
before the age of 40 years in men. They are more likely to have an 
anterior location of infarction and are significantly younger at the time of 
first hospitalisation for heart failure. CAD in Indians is known to be 
severe, extensive and malignant despite a lower age and a greater 
proportion of non smokers. 
 CAD mortality rates are 2 fold higher in Asian Indian women of 
45-64 years of age than in whites2. 
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Prevalence of CAD in India: 
 In India the number of deaths due to CAD was 1.17 million in 1990 
and 1.59 million in 2000. It is projected to be 2.03 million by 20103.  
 The prevalence of CAD in urban India is double the rate than in 
rural India. The rates appear to be higher in south India with Kerala 
having a prevalence of 13% in urban areas and 7% in rural areas. CAD 
prevalence is New Delhi is 10% and in Chennai, it is 11% (2) These rates 
are similar to those among more affluent overseas Indians.  
 This excess burden of CAD in Asian Indians is due to a genetic 
susceptibility, mediated through elevated levels of lipoprotein which 
magnifies the adverse effects of lifestyle factors associated with 
urbanization, affluence and changes in diet. There is higher rate of 
abdominal adiposity among urban population, which results in significant 
dyslipedemia and insulin resistance and a 3 fold increase in diabetes. A 
more aggressive approach to prevention and treatment of both 
conventional and emerging risk factors is warranted in Indians. 
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Risk factors for CAD 
 Risk factors for CAD can be broadly divided into modifiable and 
nonmodifiable. The modifiable one can be again divided into lipid and 
nonlipid factors.  
Non modifiable risk factors  
1. Age : 
 Male > 45 years 
 Female > 55 years 
2. Family history of premature CAD –  
 Male first degree relative < 55 years 
 Female first degree relative < 65 years 
3.  Male Sex: 
Modifiable – non lipid risk factors : 
1. Hypertension  
2. Diabetes  
3. Smoking  
4. Life style risk factors: 
 Obesity - BMI > 30kg/m2 
 Physical inactivity 
 Atherogenic diet  
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Modifiable – Lipid risk factors: 
1. Total cholesterol > 200 mg /dL  
2. Triglyceride  > 150 mg /dL 
3. HDL   < 40 mg /dL 
4. LDL   > 100 mg /dL 
New emerging risk factors  
1. Impaired fasting glucose  
2. Homocysteine > 15 µmol/L  
3. Subclinical atherogenesis  
4. Prothrombotic factors  
5. Proinflammatory factors  
 
JAMA 285, 2486 ; 2001. 
 
Coronary risk factors for Asian Indians4   
Fixed  
 Male age > 25 years 
 Female age > 45 years 
 Family history of premature CAD <55 years 
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Modifiable non lipid  
 Hypertension  
 Cigarette smoking / Tobacco Abuse  
 DM/ Insulin resistance syndrome  
 Apple obesity or BMI > 22 
 Homocysteine > 10µ mol / L 
 High PAI – 1 
Modifiable lipid  
  TC  > 150 mg /dL 
  TGL  > 150 mg /dL 
  LDL  > 100 mg /dL 
  Apo b  > 100 mg /dL 
  HDL  < 40 mg /dL  in males and < 50 mg /dL  in females  
Modifiable lipoprotein ratio  
  LDL / HDL > 3.5  
  TC / HDL > 4.5 
  Apo a / Apo b < 1.2 
  Lipid Tetrad = Lp(a) x TG x LDL / HDL > 20000 mg/dl 
 [API text book of medicine – 7th edition p – 433]              
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 CAD risk factors can also be classified as conventional and 
emerging risk factors. Compared to other ethnic groups, Indians have a 
lower prevalence of H.T, hypercholesterolemia, obesity and smoking, but 
a higher prevalence of high triglycerides, low level of HDL, glucose 
intolerance and central obesity. Although the conventional risk factors do 
not fully explain the excess burden of CAD, these risk factors appears to 
be doubly important and remains the principal target for prevention and 
treatment.  
Hypertension  
 Hypertension is a strong risk factor for CAD. It accelerates the 
atherosclerotic process especially if Hyperlipedemia is also present. 
Recent data shows that even high normal levels (SBP 130-139mm of Hg 
and DBP 85-89mm of Hg) are associated with doubling of CAD risk5. 
Hypertension is closely related with salt intake, alcoholism and obesity.  
Generalised obesity  
  The majority of the patients with CAD are overweight and severity 
of the disease is more in them. Obesity markedly reduces the life span by 
about 22% (Kevin P et al6). Obesity is associated with increased risk of 
hypertension, diabetes, dyslipidemia and CAD. 
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BMI (Body mass index) which is defined as the weight in kilogram 
divided by height in meter squares is now accepted as an  important 
measure of obesity.  
Classification of overweight and obesity by body mass index (Kg/m2)  
 Underweight  <18.5 
 Normal   18.5 – 24.9 
 Overweight   25.0 – 29.9 
Obesity      
  Class I  -  30.0 – 34.9 
  Class II - 35.0 – 39.9 
Class III - >40  
(Extreme obesity) 
[API Text Book] 
 The drawback of BMI is it does not convey information about the 
distribution of body fat. South Asians have increased abdominal visceral 
fat and greater insulin resistance at lower levels of BMI, which suggest 
that reliance on BMI alone may underestimate true risk in our population. 
Now WHO has revised obesity cut off for Asians from BMI ≥ 30 to BMI  
≥ 257. 
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Cut off points of BMI for Asian Indians (Hubbard vs)8 
  Underweight  <18.5 
 Normal range  18.5 – 22.9 
 Overweight   ≥ 23 
  At risk  - 23 – 24.9 
  Obese I  - 25 – 29.9 
  Obese II  -  ≥ 30 
Apple type and pear shaped obesity  
 On the basis of body fat distribution, obesity may be classified into 
android and gynoid types.  
 Android obesity is the collection of fat mostly in the abdomen 
(above the waist). It is also called central obesity and is associated with an 
increased risk of metabolic complications such as CAD, DM, HT and 
dyslipidemia. It is the most common acquired cause of insulin resistance. 
Also known as apple type body. 
 Gynoid obesity (Pear shaped body) is the collection of fat on the 
hips and buttock (below the waist or gluteo femoral). This makes the 
person more prone to mechanical disorders such as varicose vein and 
disorders of the joint.  
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Measurement of central obesity  
Waist hip ratio (WHR) 
    The usual measure of central obesity is waist hip ratio. Since the 
excess fat is usually concentrated in the hip in women and the waist in 
men, the optimum value for the waist hip ratio is lower in women (<0.85) 
than in men (<0.95). In Indians the average waist hip ratio in men is 0.93 
and in women is 0.844.    
 Waist hip ratio >1.0 in men and >0.9 in women is abnormal 
(Harrison p.422) and is associated with high morbidity and mortality 
(Kumar and Clark). Waist hip ratio <0.9 in men and <0.8 in female have a 
good prognosis11. Waist hip ratio >0.88 in females is an independent risk 
factor for the development of CAD12. 
Waist circumference  
    Recently waist circumference has been found to be an even better 
market of central obesity than waist hip ratio. For Asian Indians the 
optimum waist circumference is <80cm in women and <90cm in men2. In 
men there is increased risk if the waist circumference is 94cm or more and 
substantial risk if it is 102cm or more4. For women the figures are 80 and 
88cms respectively.  
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Diabetes Mellitus  
 Both diabetes and impaired glucose tolerance are associated with 
increased cardiovascular risk. A recent study in India showed a 
prevalence of diabetes and IGT as 12.1% and 15% respectively14.         
 Diabetes is associated with central obesity, hypertension, 
atherogenic dyslipidemia and insulin resistance, all of which have been 
associated with high CAD risk. Diabetic dyslipidemia consists of elevated 
triglyceride, low HDL, and an increased proportion of small dense LDL.  
Metabolic syndrome  
  Metabolic syndrome refers to a specific clustering of cardiovascular 
risk factors (abdominal obesity, atherogenic dyslipidemia, elevated BP, 
insulin resistance, a prothrombotic state and a pro inflammatory state) in 
the same individual. It is also known as insulin resistance syndrome, 
metabolic syndrome, or cardiometabolic syndrome ‘X’. The patient with 
this syndrome are at increased risk for development of diabetes and 
cardiovascular disease.  
Pathogenesis of metabolic syndrome13  
 Central obesity has a key role in the pathogenesis of metabolic 
syndrome. Visceral adipose tissue (VAT) refers to fat cells located within 
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the abdominal cavity and includes omental, mesenteric retroperitoneal and 
perinephric adipose tissue. In lean individuals VAT represents 20% of fat 
in men and 6% of fat in women. Obese individuals have an expanded fat 
cell mass characterised by visceral adiposity. The increase in insulin 
resistance with weight gain is directly related to the amount of VAT.  
Normal insulin action  
 In the fasting state approximately 85% of glucose production is 
derived from the liver with remainder produced by the kidney. 
Metabolism of glucose by muscle requires insulin. In the fed state, 
carbohydrate ingestion leads an increase in plasma glucose concentration 
and stimulates insulin release from the pancreatic beta cell. The resultant 
elevation in plasma insulin (1) suppress hepatic glucose production and 
(2) stimulates glucose uptake by peripheral tissues. The majority of 
glucose that is taken up by peripheral tissues is disposed in muscle, with 
only a small amount (4-5%) being metabolised by adipocytes.  
 Although the fat tissue is responsible for only a small amount of 
total body glucose disposed, it plays a very important role in the 
maintenance of total body glucose homeostasis through the release of free 
fatty acids (FFA). Small increments in plasma insulin exert a potent 
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antilipolytic effect, leading to a marked reduction in the plasma FFA 
level. The decline in plasma FFA levels results in increased glucose 
uptake in muscle and reduces hepatic glucose production.  
 Visceral fat cells have a high lipolytic rate which is especially 
refractory to insulin. Increased lipolysis of fat results in elevation of 
plasma FFAs and cause insulin resistance in muscle and liver and impairs 
insulin secretion. Obese individuals have increased FFA levels in their 
blood. FFAs are stored as triglycerides in adipocytes. Obese individuals 
also have increased stores of triglycerides in muscle and liver and the 
increased fat content correlates closely with insulin resistance in these 
tissues. Finally FFA released into the portal circulation drain into the liver 
where they stimulate production of VLDL particles.  
 Visceral fat cells are active endocrine cells producing many 
cytokines including leptin, tumor necrosis factor alpha, interleukin6; 
plasminogen activator inhibitor -1 (PAI-1) angiotensinogen, resistin and 
CRP. These adipokines drain into portal circulation and reduce insulin 
sensitivity in peripheral tissues.  
 VAT is also the source of anti-inflammatory, antiatherosclerotic 
adipokines known as adiponectin, a hormone associated with increased 
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insulin sensitivity. Obesity is associated with decreased levels of 
adiponectin. Studies have demonstrated abnormalities in adiponectin-
insulin sensitivity axis in non diabetic South Asians, which may be an 
important to atherogenesis, in this population7. Raji et al showed lower 
levels of adiponectin in Asian Indians.  
 Increased VAT may also leads to elevated level of cortisol, which 
would increase insulin resistance.  
 Fat cell size is an important predictor of diabetes. Small newly 
differentiated adipocytes are more insulin sensitive than large, lipid rich 
fat cells. The smaller cells are able to take up glucose and store lipid. In 
contrast, the larger cells have low rates of insulin stimulated glucose 
uptake, less suppression of lipolysis and a higher rate of cytokine 
production. Visceral fat cells tend to be larger and more metabolically 
active than subcutaneous fat cells.  
 Thus as defined by NCEP-ATP metabolic syndrome primarily is a 
clustering of metabolic complications of obesity.             
 Prevalence of metabolic syndrome varies according to the 
definitions used and the population studied.  
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Criteria proposed for clinical diagnosis of metabolic syndrome 
Clinical measure  WHO (1998) ATP III (2001) 
Insulin resistance  IGT, IFG or lowered 
insulin sensitivity plus any 
two of the following  
None, but any 3 of the 
following 5 features  
Body weight  Men: WHR >0.90 
Women: WHR >0.85 
and /or BMI >30kg/m2 
WC ≥102 cm in men 
or ≥ 88cm in women  
Lipid  TG >159 mg/dL and/or 
HDL-C <35mg/dL in men  
or <39mg/dL in women  
TG>150mg/dL    
HDL-C <40mg/dL in 
men or <50mg/dL in 
women 
Blood pressure  >140/90 mmHg ≥130/85 mmHg 
Glucose  IGT, IFG or T2DM >110 mg/dL (includes 
diabetes)  
Other  Microabluminuria  Other features of 
insulin resistance  
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 The criteria by WHO and ATP III for diagnosing metabolic 
syndrome may not be appropriate for Asians. IDF (International diabetes 
federation) had made a first attempt to provide ethnic group specific cut 
off points for some risk factor such as waist circumference.    
IDF criteria for metabolic syndrome  
 Increased waist circumference (population specific) plus any 2 of 
the following: 
• TGL ≥ 150mg/dL or on specific treatment for TGL 
• HDL <40mg/dL in men or <50mg/dL in women or          
on treatment for this lipid abnormality. 
• BP ≥ 130 mm of Hg systolic or ≥ 85mm of Hg diastolic 
or         on antihypertensive treatment.   
• Fasting plasma glucose ≥ 100mg/dL (includes diabetes). 
Ethnic specific values for waist circumference  
 Country / Ethnic group  
 Europeans  
  Men   >94 cm 
  Women  >80 cm 
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 South Asian, Chinese  
  Men   >90 cm 
  Women  >80 cm  
 Japanese  
  Men   >85 cm 
  Women  >90 cm 
 Subjects with the metabolic syndrome face 2 fold greater risk of all 
cause mortality and 2-3 fold increased risk of cardiovascular mortality 
compared with those without the syndrome (Gupta et al). The syndrome is 
particularly common among Asian Indians.  
 Love grove JA in his study “CVD risk in south Asians” the 
importance of defining adiposity and influence of dietary 
polyunsaturated fat”15 says that south Asians have a higher central 
obesity and greater CVD risk associated with a lower BMI. Low dietary 
intakes and tissue level of long chain fatty acid (LC n-3 PUFA) in South 
Asian population have been linked to high risk abnormalities in the 
metabolic syndrome. Increasing the dietary intake of LCN-3 PUFA in 
south Asians has proved as effective strategy for correcting such 
abnormalities as dyslipidemia in metabolic syndrome.  
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LIPID ABNORMALITIES OF CAD 
 
Low HDL  
 HDL is the only known carrier of cholesterol from peripheral 
tissues to liver i.e. reverse cholesterol transport, which is a protective 
mechanism against atherogenesis. Each 1mg HDL cholesterol is   
estimated to decrease CAD evens by 2-4%16. HDL >60 is a “negative” 
coronary risk factor. A low HDL is associated with increased risk of CAD 
even if TGL and TC levels are not elevated. A 10mg/dL fall in HDL 
confers the same risk for CAD as 30mg/dL increase in LDL. In general 
Indians had HDL level 5 mg/dL lower than Europeans and American 
white16. A study on Asian Indians living in the United States found that 
54% of men had an HDL level below 40mg/dL and 68% of women had 
levels below 50mg/dL South Asians not only have lower HDL level but 
also have a higher concentration of small, less protective HDL particles, 
which suggests impaired reverse cholesterol transport (2).  
High triglyceride  
      About 95% of triglyceride (TG) in body is stored in adipose tissue 
as glycerol fatty acids and mono glycerides. An 88mg/dL increase the 
relative risk of CAD by 30% in men and 75% in women. Paris 
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prospective study and NCEP ATP17 III guide line has accepted 
triglycerides as an important risk factor for CAD. Johnson SL et al118. In 
STRIDE had noticed higher significance of TG in female CAD. The same 
was noted by Gupta et al19 and Acarteik et al20.       
 Low TG – high HDL levels have a lower risk of CAD, but this 
profile is uncommon among Asian Indians. 
Total cholesterol  
  An elevated total cholesterol is a strong risk factor for CAD. Total 
cholesterol levels and LDL levels are correlated with extent and severity 
of CAD in Asian Indians as in whites. But at any given total cholesterol or 
LDL level, Asian Indians a greater CHD risk than white. A recent study 
has shown an eight fold higher CAD mortality with an increase in TC 
from 160 to >280mg/dL. Therefore Asian Indians with dyslipidemia 
should be treated as aggressively as if they had a CHD risk equivalent – 
similar to the treatment of patients with diabetes or heart disease. The 
optimum level of total cholesterol appears to be 150mg/dL for Asian 
Indians.  
 A TC/HDL of >4.5 has high CAD risk. The ratio <3.5 has been 
recommended as clinical goal for CAD prevention27.     
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LDL cholesterol   
 Although South Indians have levels of LDL cholesterol comparable 
to other population, LDL particle size tends to be smaller. Small LDL 
particles through increased susceptibility to oxidation are more 
atherogenic than larger particles.  
Lipoprotein (a) [Lp(a)] 
 Lp (a), a variant of LDL is a strong independent risk factor for 
premature CAD. Lp (a) is often the link between atherosclerosis and 
thrombosis. It is highly thrombogenic and  antifibrinolytic, by virtue of its 
homology to plasminogen. The term “deadly cholesterol” is used to 
denote Lp(a). Lp (a) levels are governed by age, gender, diet and other 
environment factors. Childhood levels of Lp(a) are a better predictor and 
marker of future CAD in young adult life than any other lipoproteins. 
Although Lp(a) levels >30mg/dL are generally considered the threshold at 
which high risk of premature CAD increases rapidly, levels below 15-
20mg/dL are considered optimum2. Studies of Asian Indians in North 
America found that 25% to 50% of sampled populations have levels 
>30mg/dL. 
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Physical inactivity  
 Regular physical exercise reduces myocardial oxygen demand and 
increases exercise capacity. The cardioprotective effects of exercise 
include decreased adiposity and diabetes incidence, lowered blood 
pressure and improvement of dyslipidemia, plasma rheology and vascular 
inflammation. Exercise enhance the insulin sensitivity.  
Tobacco abuse  
   Smoking remains the single most important modifiable risk factor 
for CAD and the leading preventable cause for CAD. Current smoking of 
>10 cigarettes or beedi a day is associated with a 6-7 fold increase in the 
risk of MI. Smoking affect atherothrombosis by several other mechanism. 
Long term smoking may enhance oxidation of LDL and impairs 
endothelial dependent coronary artery dilation. Smoking has adverse 
hemostatic and inflammatory activity including increased level of hs CRP, 
intercellular adhesion molecule-1 (ICAM-1), fibrinogen, homocysteine 
and  spontaneous platelet aggregation. Smokers have increased prevalence 
of coronary spasm and may have reduced threshold for ventricular 
arrhythmia. Asian Indian women have a low rate of smoking. But they 
may be harmed by passive smoking. The risk of CAD begins to decline 
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within months of smoking cessation and disappears within 3-5 years. 
Socioeconomic status: CAD has now become a disease of the poor in 
rich countries and of the rich in poor countries. Asian Indians with a low 
SES have a higher prevalence of CAD.    
Psycho social factors: Depression, hostility and anger and low social 
support are associated with CAD. Contrary to common belief, type A 
personality is not associated with an excess of CAD. More than that the 
prognosis of CAD among type A persons is better than in type B patient.   
Emerging cardiac risk factors 
 The identification of newer methods of risk stratification has been 
an area of active research. Lipoprotein(a), apo lipoprotein B, 
homocysteine, plasminogen activator inhibitor-1, pro inflammatory 
adipokines levels tend to be higher in south asian. These factors support a 
prothrombotic milieu. Micro albuminuria is recognised as an independent 
cardiovascular disease risk factor. 
Asian Indian paradox  
 The high rates of CAD in Asian Indians are accompanied by low 
rates of conventional risk factor except for diabetes. For Asian Indians 
physical activity was high and saturated fat consumption was low. The 
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high rate of CAD among Asian Indians despite these enviable levels of 
risk factors suggest an important role of genetic risk factor.  
Prevention of CAD in Asian Indians  
 It seem appropriate to begin preventive strategies at an earlier age 
in Asian Indians because of the extreme prevalence and of malignant 
nature of CAD.  Modification of life style, such as increasing physical 
activity and decreasing consumption of calories particularly saturated fat 
should begin early in life. Consumption of all types of tobacco products 
should be eliminated. Clinician should remain aware of the increased 
prevalence of metabolic syndrome and glucose intolerance in south 
Asians. Screening methods should include waist circumference rather 
than WHR and BMI. Assessment of fasting glucose and complete lipid 
profile are essential. Reduction of abdominal obesity through lifestyle 
measures can improve all components of the metabolic syndrome and 
likely delay the development of both diabetes and atherosclerosis. 
Appropriate drug therapy should be considered for all lipid abnormalities 
and for the  risk factor abnormalities which do not respond to life style 
modification. 
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AIM OF THE STUDY 
 
1. To study the significance of waist circumference as an important 
risk factor for coronary artery disease in females.  
 
2. To study the significance of waist-hip-ratio with coronary artery 
disease in females.  
 
3. To correlate the association of metabolic syndrome with coronary 
artery disease in females.  
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MATERIALS AND METHODS 
    
Setting:  
 Female patients with acute myocardial infarction admitted to 
medical ward and intensive coronary care unit of Government Rajaji 
Hospital, Madurai.   
Collaborating departments  
  Department of Cardiology,  
 Madurai Medical College,  
 Madurai.  
 Department of Biochemistry,  
 Madurai Medical College,  
 Madurai.  
Design of study : case control study  
Period of study: 1 year  
Sample size: 80 cases and 24 controls  
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Selection of subjects  
 80 female patients admitted with acute myocardial infarction in 
medicine and cardiology department of Government Rajaji Hospital from 
1-7-06 to 31.3.07 formed the study group.  
 Control group consisted of female attenders of patients who were in 
the same age group of the cases, without hypertension, diabetes mellitus 
and coronary artery disease. 
Inclusion criteria  
 Female patients admitted with acute myocardial infarction in 
medical ward and ICCU were taken.  
Exclusion criteria  
 Secondary causes affecting lipid profile was not taken.  
1. Hypothyrodism  
2. Nephrotic syndrome  
3. Chronic renal failure  
4. Connective tissue disorder  
5. Patients on hypolipidemic drugs, diuretics, β blockers  
6. Patient with previous history of CAD on hypolipidemic drugs  
7. Patient with AMI who were not willing to participate in the study  
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DEFINITION  
Acute MI – The criteria for diagnosis of acute MI was done by  
1. Definite clinical history  
2. Electrocardiographic changes and was supported by 
echocardiogram  
Hypertension -  is diagnosed to be present if patients was on anti 
hypertensive medication or if blood pressure during hospital stay was 
found to be more than 140mm Hg systolic or 90mmHg diastolic 
according to JNC VII definition.  
Diabetes - Patient was considered to be diabetic if she was 
diagnosed earlier or was on anti diabetic treatment or on admission, found 
to have fasting plasma glucose more than 126mg% or postprandial of 
more than 200mg%. 
Obesity -  The patient was considered to be obese if  her body mass 
index calculated by wt in kg /Ht in m2 was > 25 Kg /m2. 
Waist circumference - Abdominal girth at the level of equidistant 
between costal margin and illiac crest. ≥ 80cm is taken as abnormal.  
Hip circumference - Body girth at the level of greater trochanter is 
measured.  
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Waist hip ratio is the ratio calculated by dividing waist 
circumference by hip circumference. Value > 0.85 is taken as abnormal.  
Lipid profile Consists of total cholesterol, TG, LDL, HDL and 
VLDL done by direct enzymatic assay.  
Metabolic syndrome was diagnosed according to IDF criteria 
(MS1) and ATP III criteria (MS2). 
Localization of infarction  
 Site of infarction is localized according to criteria of committee of 
New York Heart Asso using 12 lead ECG, including V3R and V4R and 
also using ECHO. 
 The sites were divided into anterior, anteroseptal, inferior, inferior 
with right  ventricular, inferior with posterior infarction, inferior  with 
posterior  and right ventricular extension and lateral wall MI.  
Ejection fraction  
 EF was divided into 3 groups.  
> 50% was taken as normal, 40-49% mild, 30-39% moderate, and 
<30 severe left ventricular dysfunction.  
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DETAILS OF THE STUDY 
 
 80 female patients with proven MI were taken as cases. 24 age 
matched females without coronary heart disease, HT and diabetes  were 
taken as controls. Detailed history regarding present illness, past illness, 
treatment history and personal history was taken. Clinical examination 
including blood pressure monitoring and anthropometric measurements 
was done. Fasting and post prandial blood sugar, lipid profile, blood urea, 
s.creatinine, ECG and Echo were done both for cases and controls. By 
history, clinical examination and biochemical analysis, secondary causes 
of elevated lipid profile was excluded. The collected datas were analysed 
for correlation with coronary artery disease. 
 
Ethical approval : Obtained  
Consent  : Informed consent was obtained 
Financial support  : Nil        
Conflict of interest : Nil  
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STATISTICAL ANALYSIS  
 
 
 The information collected regarding all the selected cases were 
recorded in a master chart. Data analysis was done with the help of 
computer using Epidemiological information package (EPI 2002). Using 
this software, frequencies, percentages, mean, standard deviation, α 2 and 
‘p’ values are calculated. A ‘p’ value less than 0.05 is taken to denote 
significant relationship. 
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A. Characteristics of Cases and controls 
Table 1 
Age Distribution 
Study Group Control Group Age in years 
No. % No. % 
Less than 40 - - - - 
40-49 12 15 7 29.2 
50-59 38 47.5 11 45.8 
60-69 25 31.3 6 25 
70 & above 5 6.2 - - 
Total 80 100 24 100 
Mean 
S.D. 
56.6 yrs 
7.7 yrs 
53.7 yrs 
7.2 yrs 
P 0.2041 (Not significant) 
 
 Mean age in study were 56.6 with S.D 7.7 years. Control group 
mean age was 53.7 with S.D of 7.2 yrs. P value 0.2041 The difference 
was statistically not significant ie the two groups were comparable. 
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Table 2 
Other Demographic Characteristics 
 
Study Cases Control cases Characteristics 
No. % No. % 
‘p’ 
Domicile 
a) Urban  
b) Rural 
 
32 
48 
 
40 
60 
 
10 
14 
 
41.7 
58.3 
 
0.9273  
(Not significant) 
Employed 
a) Yes 
b) No 
 
12 
68 
 
15 
85 
 
6 
18 
 
25 
75 
 
0.2005 
(Not Significant)
Socio Economic Status 
a) High 
b) Low 
 
18 
62 
 
22.5 
77.5 
 
6 
18 
 
25 
75 
 
0.983  
(Not significant) 
Life Style 
a) Sedentary 
b) Not Sedentary 
 
54 
26 
 
67.5 
32.5 
 
18 
6 
 
75 
25 
 
0.6555  
(Not Significant)
Diet  
a) Vegetarian 
b) Non vegetarian 
 
- 
80 
 
- 
100 
 
- 
24 
 
- 
100 
 
- 
Tobacco smoking 
a) Present 
b) Absent 
 
- 
80 
 
- 
100 
 
- 
24 
 
- 
100 
 
- 
Personality Type 
A 
B 
 
19 
61 
 
23.8 
76.3 
 
2 
22 
 
8.3 
91.7 
 
0.0812  
(Not Significant)
Menstrual Status 
a) Premenopausal 
b) Post Menopausal 
 
9 
71 
 
11.3 
88.8 
 
3 
21 
 
12.5 
87.5 
 
0.5568 
(Not Significant)
 
 Other demographic parameters like domicile, employment status, 
socioeconomic status, life style, diet, tobacco smoking, personality type 
and menstrual status of the cases and controls compared. The difference 
between the groups were not statistically significant. 
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Table 3 
Risk Factors 
Study Cases Control cases Risk Factors 
No. % No. % 
‘p’ 
HT 
a) Present 
b) Absent 
 
41 
39 
 
51.3 
48.8 
 
- 
24 
 
- 
100 
 
0.0002 
(Significant) 
DM 
a) Present 
b) Absent 
 
28 
52 
 
35 
65 
 
- 
24 
 
- 
100 
 
0.0018 
(Significant) 
CVA 
a) Present 
b) Absent 
 
- 
80 
 
- 
100 
 
- 
24 
 
- 
100 
 
- 
OCP use 
a) Present 
b) Absent 
 
1 
79 
 
1.3 
98.2 
 
- 
24 
 
- 
100 
 
0.7692  
(Not Significant) 
Family History 
a) Present 
b) Absent 
 
15 
65 
 
18.8 
81.3 
 
4 
20 
 
16.7 
83.3 
 
0.5416  
(Not significant) 
 
 The risk factors for CAD like hypertension, diabetes, 
cerebrovascular accidents, OCP use and a family history of the two 
groups were compared. 
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 There was no significant difference between these two groups 
except for hypertension and diabetes (we have taken controls without 
hypertension and diabetes). 
 Incidence of H.T among cases were 51.3%. Incidence of D.M 
among cases were 35.0%. Incidence of CVA among cases and control 
were zero. 
 Only one case had history of OCP use, with none in the control 
group. Family history of CAD was present in 18.8% of cases and 16.7% 
of control. The difference was not statistically significant. 
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Anthropometric measurement 
Table 4 
Height,    Weight,   and BMI 
 
Study Cases Control cases Parameters 
Mean S.D. Mean  S.D. 
‘p’ 
Height (in cms) 147.8 5.7 149.3 7.1 0.1835  
(Not significant) 
Weight (in kg) 55.2 9.3 46.5 6.8 0.0001 
(Significant) 
BMI 25.3 4.1 20.7 2.6 0.0001 
(Significant) 
 
Height - Mean height in the study groups was 147.8cm with S.D of 
5.7 cm. Mean height in the control groups was 149.3 cm with a S.D of 7.1 
cm. The p value was 0.1835 which was statistically not significant. 
Weight (in kg) - Mean weight of the study group was 55.2 with 
S.D of 9.3 kg. Mean weight of the control group was 46.5 kg with of S.D 
of 6.8kg. The difference was statistically significant. P value 0.0001.  This 
shows the significance of over weight as a risk for CAD. 
BMI - Mean BMI of the study group was 25.3 with a S.D of 4.1 
The mean BMI of control group was 20.7 with a S.D of 2.6. P value 
0.0001. The difference was statistically significant, showing the 
significance of obesity as an important risk factor for CAD. 
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Table – 5 
Waist circumference and WHR 
Study Cases Control cases Parameters 
Mean S.D. Mean  S.D. 
‘p’ 
Waist 
Circumference in 
cms 
 
87.5 
 
9.7 
 
77.5 
 
5 
0.0001 
(Significant) 
Hip 
Circumference in 
cm 
 
90.8 
 
7.5 
 
83.8 
 
5.1 
0.0001 
(Significant) 
 
W/H Ratio 
 
0.96 
 
0.07 
 
0.92 
 
0.03 
0.0001 
(Significant) 
 
Waist circumference 
  The mean waist circumference (W.C) in study group was 
87.5 with a S.D of 9.7 and the W.C of control group was 77.5 with a S.D 
of 5. P value 0.0001.  The difference was statistically significant, showing 
that  central obesity is an important risk factor for CAD. 
 
W.H.R 
 The mean W.H.R in the study group was 0.96 with S.D of 0.07. 
The mean W.H.R of control group was 0.92 with S.D of 0.03. P value 
0.0001.  The difference was statistically significant. This again shows the 
significance of central obesity as an important risk factor for CAD. 
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Table – 6 
Lipid profile 
Study Cases Control cases Parameters 
Mean S.D. Mean  S.D. 
‘p’ 
TC 186.3 50.4 162.5 34.4 0.0473 
(Significant) 
TGL 179.3 61.8 140.8 53.2 0.0025 
(Significant) 
HDL 42.6 4.8 44.1 4.0 0.2096  
(Not significant) 
LDL 105.3 46.9 78.8 31.8 0.0089 
(Significant) 
TC/HDL 4.38 1.37 3.66 0.82 0.0303 
(Significant) 
  
TC 
 The mean total cholesterol in the study group was 186.3 with a S.D 
of 50.4. The mean total cholesterol in the control group was 162.5 with a 
S.D of 34.4. P value 0.0473. The difference was statistically significant 
showing that high total cholesterol is an important risk factor for CAD. 
TGL  
 The mean TGL (triglyceride) in the study group was 179.3 with 
S.D of 61.8. The mean TGL of control group was 140.8 with a S.D of 
53.2. P value 0.0025. 
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 The difference was statistically significant and shows that high 
TGL is an important risk factor for CAD. 
HDL 
 The mean HDL in the study group was 42.6 with S.D of 4.8. The 
mean HDL of the control group was 44.1 with a S.D of 4.0 HDL level has 
an inverse relation with CAD risk. HDL was low in the study group 
compared to control. But the difference was statistically not significant   
(P value 0.2096). 
LDL 
 The mean LDL of the study group was 105.3 with a S.D of 46.9 
 The mean LDL of the control group was 78.8 with S.D of 31.8. P 
value 0.0089.  The difference was statistically significant showing that 
high LDL is an important risk factor for CAD. 
TC/HDL  
Mean TC/HDL ratio in the study group was 4.38 with S.D of 1.37, 
mean TC/HDL of control group was 3.66 with a S.D of 0.32. The 
difference was statistically significant showing that  a high TC/HDL is an 
important risk factor for CAD. 
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Table 7 
Metabolic Syndrome (MS1- by  IDF criteria) 
Study Group Control Group MS1 
No. % No. % 
Present 57 71.2 6 25 
Absent 23 28.8 18 75 
‘p’ 0.0001 (Significant) 
 
 
Metabolic syndrome by IDF criteria (MS1)  
 
 The percentage of M.S in the study group was 71.2%. The 
percentage of M.S in the control group of 25%. P value 0.0001 The 
difference was statistically significant showing the significance of 
metabolic syndrome as an important coronary risk factor. 
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Table 8 
Metabolic Syndrome (MS2 – by ATP III Criteria ) 
Study Group Control Group MS2 
No. % No. % 
Present 53 66.3 3 12.5 
Absent 27 33.7 21 87.5 
‘p’ 0.0001 (Significant) 
 
Metabolic syndrome by ATP III criteria (MS2) 
 In the study group percentage of metabolic syndrome was 66.3% 
and in the control group 12.5%. P value 0.0001. The difference was 
statistically significant.  
 
 By using IDF criteria, more number of metabolic syndrome were 
identified. So for the defection of metabolic syndrome in our population 
IDF criteria is a better option. 
 
 
 
 
 43
B. Abnormalities in the two groups 
Table 9 
Comparison of waist circumference between cases and controls 
 
Study Group Control Group 
Waist Circumference 
No. % No. % 
Classification I with 80 cms as cut off 
a) Normal (< 80 cms) 
b) Abnormal (> 80 cms) 
 
12 
68 
 
15 
85 
 
14 
10 
 
58.3 
41.7 
‘p’ 0.0001 (Significant) 
Classification II with 88 cms as cut off 
a) Normal (< 88 cms) 
b) Abnormal (> 88 cms) 
 
37 
43 
 
46.3 
53.8 
 
24 
- 
 
100 
- 
‘p’ 0.0001 (Significant) 
  
Classification I – with 80 cm as cut off value.  There was 85% of cases 
with waste circumference ≥ 80 cm in the study group. There was 41.7% 
of control group had waist circumference ≥ 80cm. P value 0.0001. The 
difference was statistically significant. 
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           Classification II – with 88 cms as cut off, percentage of study 
group with ≥ 88cm waist circumference was 53.8%. percentages of 
control with ≥ 88 cm waist circumference was zero. P value 0.0001. 
 
 The difference was statistically significant. 
 
 By using waist circumference cut off value as 80 cm instead of 88 
cm, we can defect more number of cases with increased risk for coronary 
artery disease. So for screening of our population, it is better to use waist 
circumference cut off value  ≥ 80cm as abnormal. 
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Table 10 - A 
Waist hip Ratio 
Study Group 
Control 
Group Waist Hip Ratio 
No. % No. % 
Normal (< 0.85) 
Abnormal (> 0.85) 
7 
73 
8.8 
91.3 
- 
24 
- 
100 
‘p’ 0.1495 (Not Significant) 
  
Waist hip ratio (WHR) 
 Percentage of study group with WHR ≥ 0.85 was 91.3%. 
percentage control group with WHR ≥ 0.85 was 100%. P value 0.1495. 
 The difference was not  statistically significant i.e, it is better not to 
use WHR cut off value at ≥ 0.85 as abnormal in our population. 
Table 10 - B 
WHR with different cut off levels 
 In this, we categorised the cases and control with 4 different groups 
as cut off value of WHR as 0.8; 0.84, 0.88 and 0.92. The difference 
between the two groups was statistically significant only when WHR cut 
off was kept at 0.92. This shows that for our population, we have to keep 
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the WHR at a higher level. So waist circumference > 80 cm is a better 
criteria to detect females with CAD, than WHR > 0.85.  
Table – 10 B 
Waist Hip Ratio 
Study Group Control 
Group 
Waist Hip Ratio 
No. % No. % 
Group I with 0.8 as cut off 
Normal (< 0.8) 
Abnormal (>0.8) 
 
2 
78 
 
2.5 
97.5 
 
- 
24 
 
- 
100 
‘p’ 0.59 (Not Significant) 
Group II with 0.84 as cut off 
Normal (< 0.84) 
Abnormal (>0.84) 
 
7 
73 
 
8.8 
91.3 
 
- 
24 
 
- 
100 
‘p’ 0.1495 (Not significant) 
Group III with 0.88 as cut 
off 
Normal (< 0.88) 
Abnormal (>0.88) 
 
 
9 
71 
 
 
11.3 
88.8 
 
 
2 
22 
 
 
 
8.3 
91.7 
‘p’ 0.5111 (Not Significant) 
Group IV with 0.92 as cut 
off 
Normal (< 0.92) 
Abnormal (>0.92) 
 
 
11 
69 
 
 
13.8 
86.3 
 
 
11 
13 
 
 
45.8 
54.2 
‘p’ 0.002 (Significant) 
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Table – 11 
BMI 
 
Study Group Control 
Group 
BMI 
No. % No. % 
Classification I with 25 as 
cut off 
a) Normal (< 25) 
b) Abnormal (> 25) 
 
 
39 
41 
 
 
48.8 
51.3 
 
 
23 
1 
 
 
95.8 
4.2 
‘p’ 0.0001 (Significant) 
Classification II with 23 as 
cut off 
a) Normal (< 23) 
b) Abnormal (> 23) 
 
 
22 
58 
 
 
27.5 
   72.5 
 
 
21 
4 
 
 
83.3 
27.7 
‘p’ 0.0056 (Significant) 
  
 
Classification 1 with 25 as cut off  
 
 Percentage of study group with BMI > 25 was 51.3%. Percentage 
of control group with BMI > 25 was 4.2%. P value 0.0001. The difference 
was statistically significant. 
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Classification II with 23 as cut off  
 Percentage of study group with BMI > 23 was 72.5%. Percentage 
of control group with BMI > 23 was 27.3. P value 0.0056.  The difference 
was statistically significant. 
 
 The shows that, by using the BMI of value ≥ 23 as abnormal 
instead of ≥ 25, the more number of cases was detected (72.5% vs 
51.3%).       
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Table – 12 
Waist circumference and BMI 
Waist circumference 
<80 cm >80 cm 
 
BMI 
No % No % 
BMI>25  
(41) 
Zero Zero 41 100% 
BMI < 25 12 30.8% 27 69.2% 
P value 0.0004. significant 
 
On comparing waist circumference and BMI, in our study 41 out of 
80 cases had BMI > 25. All the cases (100%) with BMI >25 had waist 
circumference >80 cm. Off the 39 patients with BMI <25 , only 69.2% 
had waist circumference  > 80cm the P value is 0.0004. (significant) this 
shows that there is a significant association between waist circumference 
>80cm and BMI > 25. 
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Table 13-A 
WAIST CIRCUMFERENCE AND H.T 
 Waist circumference 
< 80cm >80cm 
No % No % 
Total No of 
HT (41) 
5 12.2% 36 87.8 
 
 41 cases of the study group had HT. Off these 87.8% had waist 
circumference > 80 cm. 
Table 13-B 
WAIST CIRCUMFERENCE AND DIABETES 
Waist circumference 
< 80cm >80cm 
No % No % 
 
 
Total No of 
D.M.(28) 
 
 2 7.1% 26 92.8% 
  
28 cases of the study group were diabetic. 92.9% of them had waist 
circumference > 80cm.  
Tables 13A and 13B, Shows that waist circumference > 80cm is 
significantly associated with H.T. and diabetes.  
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Table – 14 
Waist circumference and lipid profile 
 
Waist circumference 
<80cm >80cm 
Lipid 
profile 
Mean S.D. Mean S.D. 
P value Interpretation 
TC 
LDL 
HDL 
TC/HDL 
TGL  
157.6 
78.0 
43.7 
3.66 
136.8 
37.6 
29.9 
4.5 
0.95 
46.2 
188.5 
106.3 
42.7 
4.4 
181.6 
48.9 
47.3 
4.6 
1.35 
62.6 
0.00048
0.00075
0.5915 
0.0093 
0.0007 
Significant  
Significant  
Not Significant  
Significant  
Significant  
 
There is a significant difference between mean value of TC, TGL, 
LDL, and TC/HDL of patients with waist circumference > 80cm 
compared to that of waist circumference <80cm. This shows that waist 
circumference >80cm is associated dyslipidemia.  
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Table – 15 
Waist circumference and metabolic syndrome 
 
Waist circumference 
<80cm >80cm 
Risk 
Factors 
No. % No. % 
MS1 
Present (57) 
Absent (23) 
 
- 
12 
 
- 
52.2 
 
57 
11 
 
100 
47.8 
‘p’ 0.0001 (Significant) 
 
 57 patients of our study group had metabolic syndrome by IDF 
criteria. 100% of them had waist circumference > 80cm. 23 patients of the 
study group were not having metabolic syndrome. Only 47.8% of them 
had waste circumference > 80cm. The difference was statistically 
significant that means, as waist circumference is increases there is 
increased chance of having metabolic syndrome and thus increased 
chance for cardiovascular risk factors.  
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Table – 16  
ECG and Echo 
 
Study Group Control Group ECG Findings 
No. % No. % 
AL 2 2.5 - - 
AS 4 5 - - 
AW 37 46.25 - - 
AW & LW 2 2.5 - - 
AW & AS 3 3.75 - - 
AW & L 3 3.75 - - 
IW 27 33.75 - - 
IW & PW 1 1.25 - - 
IW & L 1 1.25 - - 
Normal Nil - 24 100 
 
 The maximum Number of infarction was anterior wall MI. Next 
was inferior MI. 
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Table - 17 
Ejection      Fraction % 
 
Study Cases Control cases 
Parameters 
Mean S.D. Mean  S.D. 
‘p’ 
EF% 42.8 9.4 58.8 4 
0.0001 
(Significant) 
 
 Mean ejection fraction of the study group was 42.8% and that of 
control was 58.8%. The difference was statistically significant. 
 
Study Group Control Group 
EF% 
No. % No. % 
Normal (>50) 
Abnormal (<50) 
14 
66 
17.5 
82.5 
24 
- 
100 
- 
‘p’ 0.0001 (Significant) 
 
100% of Control group had EF >50% only 17.5% of cases had EF>50% p 
value 0.0001. The difference was statistically significant.    
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DISCUSSION AND COMPARATIVE ANALYSIS 
 
 In my study there were 80 female patients with acute myocardial 
infarction and 24 female controls of the same age group without coronary 
artery disease, hypertension and diabetes.  
Anthropometric results  
Waist circumference  
 Mean waist circumference of our study group was 87.5cm and 
control group was 77.5cm.  
 For Asian Indians the optimum waist circumference is <80cm in 
women and <90cm in men23.  
 Waist circumference well correlate with abdominal fat content. In 
men there is increased risk if waist circumference is 94cm  or more and 
substantial risk if it is 102cm or more. For women the figures are 80cm 
and 88 cm respectively (API-text book, 7th edn.  p.265). 
 Patients with abnormal waist circumference irrespective of age, sex 
and BMI have high risk for developing CAD. This observation is 
supported by the following studies. Study by Sonmezk, Akcakoyun M, 
Akcay A et al which method should be used to determine the obesity, 
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in patients with coronary artery disease. Int. J. Obes. Relat. Metab. 
Diserd.2003;24. 
 In this study of total 617 cases with age 57.2 ± 10.8 with 
angiographically established coronary artery disease were studied. BMI, 
waist circumference WHR were compared as a whole and also within 
stratified groups of sex and age and compared with other risk factors. In 
that study the percentage of female cases with obesity with respect to BMI 
was 32%. Percentage of females with action level II waist circumference 
were 71% and percentage of female with WHR ≥0.85 was 86%. 
 In our study the mean age group was 56.6 ± 7.7 and is comparable. 
The corresponding percentages in our study was 51.3% (BMI), 85% 
(waist circumference) and 86% (WHR). These percentages are 
comparable except for that detected by BMI. This variation could be due 
to the  difference of population and ethnicity.  
 Sonmez concludes the study stating that in the same study group, 
percentage of obesity differ significantly in terms of BMI, waist 
circumference and WHR. The utilisation of BMI alone for detection of 
obesity in CAD patients may not be sufficient for precise assessment. 
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Therefore in cases with CAD,  waist circumference can be the method of 
choice for the assessment of obesity more accurately.  
 Study by TS Hans, Em Van Leer. JC seizleer MEJ Lean “Waist 
circumference action levels in the identification of cardiovascular risk 
factors25.  
 The objective of the study was to determine the frequency of 
cardiovascular risk factors in people categorised by previously defined 
“action levels of waist circumference”. 
 In that study 2183 men and 2698 women aged 20-59 years were 
selected, waist circumference, WHR, BMI, total plasma cholesterol, HDL 
level, blood pressure, age and life style was studied.  
 Result was a waist circumference 94 cm in men and 80cm in 
women correctly identified subjects with BMI ≥25 and WHR ≥0.95 in 
men and ≥0.80 in women with a specificity of 96%. 
 In our study all patient with BMI >25 had waist circumference >80 
cm with a specificity of 100%. So the level of waist circumference >80cm 
is very significant in our population for detection of females with 
increased CAD risk.  
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 The author gives the message that compared with people with waist 
circumference below action level 1 (94 cm in men and 80 cm in women), 
those with waist circumference between action level 1 and 2 (94 to 101 
cm in men and 80-87 cm in women) are one and a half to two times likely 
to have one or more major CAD risk factor. A waist circumference above 
action level 1 should be a signal to avoid weight gain, to maintain 
increased physical activity and to give up smoking.  
 People with waist circumference above action level 2 are two and a 
half to four and a half times likely to have one or more major 
cardiovascular risk factors. So the patients with a waist circumference 
above action level 2 should seek advise from health professional for 
weight management.  
 Cikim AS, Ozbey N, Orhan Y. Study “Relationship between 
cardiovascualr risk factors and types of obesity in overweight and 
obese women” J Int Med. Res. 2004 May-Jun26.  
 In this study they aimed to evaluate the relationship between types 
of obesity and cardiovascular risk factors.  
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 A total of 623 overweight (BMI >25 kg/m2) and 2559 obese (BMI 
>30kg/m2) women were divided into 4 groups according to their BMI and 
WHR.  
1. Simple over weight (BMI 25-30;  WHR <0.8) 
2. Abdominal adiposity (BMI 25-30; WHR >0.8) 
3. Peripheral obesity (BMI 25-30; WHR <0.8) 
4. Central obesity (BMI >30; WHR >0.8) 
 They found that risk indicators measured were significantly higher 
in the central obesity group. Total body fat and abdominal fat 
accumulation seems to result in more serious insulin resistance in central 
obesity.  
 Mergaret ashwell and colligues in the study “ Waist circumference 
remains useful predictor of coronary heart disease” BMJ 1996 say that 
height does not have an important role in explaining variations in the 
waist circumference. Simplicity of using the waist circumference argue 
against waist to height ratio particularly in a public health programe. 
 Balkau B, Sapinho D, Petrella et al. in the study “ Prescreening 
tools for diabetes and obesity associated dyslipidemia; comparing 
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BMI; Waist circumference  and waist hip ratio”  Eur.J. Clin. Nutr. 
2006 Mar. 
 The objective of the study was to compare  the sensitivity of BMI, 
Waist circumference and WHR in identifying subjects ‘who should be 
screened for diabetes and  or for obesity associated dyslipidemia’. The 
result of the study was for women, waist circumference had a higher 
sensitivity than BMI or WHR for detecting diabetes. For detecting 
dyslipidemia, Waist circumference  and WHR had similar sensitivities, 
higher than for BMI.  
Waist to Hip Ratio: 
 The mean WHR of our study group was 0.96. and of the control 
group was 0.92. Compared to control group, there was a significantly high 
WHR in the study group, which again stress the importance of central 
obesity as a risk factor for CAD. In Harrison9 it is given that WHR > 0.9 
in women is abnormal. 
 In our study the cut off value for WHR was kept > 0.85 as 
abnormal as per the optimum value for Asian Indians.2 and29 WHR > 0.85 
as cut off value was not statistically significant in our study. 
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 So for our population for detecting females  with high CAD risk, 
waist circumference > 80 cm as abnormal will be a  better criteria than 
WHR > 0.85. 
 In the text book of Braunwald’s heart disease (P.1954) says that, 
among women waist hip ratio greater than 0.88 is a predictor of 
substantially increased risk of cardiovascular events.  
 Arlette Cparry, Paul C Miller et al in the study30 “Clinical 
predictability of the waist to hip ratio in assessment of cardiovascular 
disease risk factor in overweight premenopausal women, Am 
J.Clinical nutr 1998; states that although the American heart association 
has reported that a WHR > 0.80 be used to indicate increased risk of 
cardiovascular disease in women, the present study assessed the WHR 
above which is seen elevations in cardiovascular disease risk factors in a 
sample of overweight women, using data from 240 women aged 27.5-
47.5.  They determined WHR quartiles: < 0.80, .80 to <0.84, 0.84 - <0.90 
and > 0.90. Subjects were placed into high risk categories for 
cardiovascular disease on the basis of age and population defined norms. 
Women had an increased likelihood of elevated VLDL, triglyceride, low 
HDL, diastolic blood pressure and composite risk (ie having > 4 CAD risk 
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factors) at a WHR > 0.90. All afore mentioned variables had a significant 
odds ratio at WHR > 0.90. They concluded that “these data suggest an 
upward shift in the critical threshold for WHR to > 0.90 , at which point 
there was an elevation in cardiovascular disease risk factors, in over  
weight  females. 
Body Mass Index 
 Mean BMI of our study group was 25.3 and that of control group 
was 20.7 According to BMI values for Asian Indians31, mean BMI of our 
study group belongs to obesity class 1 and that of control belongs to 
normal range. For Asians the optimum BMI is <23, where as 23-25 is 
considered as overweight and ≥25 obese2. In our study when we kept the 
cut off BMI  > 23 as  abnormal the difference between cases and  control 
was significant statistically, and the percentage of abnormally detected 
was increased from 51.3 % to 72.5% . So for better detection of females 
with increased CAD risk, it will be better to use BMI > 23 as  normal 
instead of > 25. The Framingham offspring study demonstrated a dramatic 
rise in risk factors for cardiovascular disease at BMI above 2032. 
Lipid profile Analysis 
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 Lipid profile analysis of our study showed that the mean total 
cholesterol, TG, LDL and TC/HDL ratio were significantly high in the 
study group compared to the control group. This shows the association of 
dyslipidemia as an important risk factor for CAD. 
 On comparing our study with the study by Binu et al37, The mean 
total cholesterol in our study was 186 mg/ dl and their study was 214 
mg/dl. Similarly the mean LDL in our study was 105 mg/dl and their 
study was 147. The mean TG in our study was 179.8 and in that study was 
152. On comparing these two study, we see that TG abnormality is high in 
our study where as total cholesterol and LDL abnormality high in Binu et 
al study. 
 This difference may be because our study group had only female 
cases, where as in that study had both males and females with  males 
number predominating. This shows the significance of increased TG as an 
important risk factor for CAD in females19,20 Gupta et al, Acartek et al. 
 Now comparing the lipid profile and waist circumference, in our 
study , there is a significant association between waist circumference > 80 
cm and ellivated levels of TC, TG, LDL, and TC/HDL ratio. This 
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significance was maximum for the association of TG. This is supported by 
study28 and37. 
 M.G.F.Lemos – Santos. MPH, et al study. “Waist circumference 
and waist to – hip ratio as predictors of serum concentrations of 
lipids in Brazilian men.”  Nutrition Oct 2004 (37) in their study multiple 
linear regression analysis was performed to quantity the association 
between fat distribution (WC and WHR) and the TC/HDL ratio and TG. 
In their study, waist circumference was strongly correlated with 
percentage of body fat ( r=0.90) where as WHR correlated less  (r=0.55) 
and they concluded waist circumference as a good predictor of lipid 
profile. 
 Our study shows that waist circumference > 80cm is a warning to 
screen for dyslipidemia in females. 
 Comparing the HDL among the cases and controls, though low 
HDL was more in the study group than the control, the difference was not 
significant. While comparing HDL and WC a low HDL was found in the 
study group with WC >80cm, though the difference was not statistically 
significant. A low HDL is very common among Indians and genetic factor 
may be involved as the cause (Enas A Enas)34. Asians not only have lower 
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HDL level but also have a higher concentration of small, less protective 
HDL particles  which suggests impaired reverse cholesterol transport 
(Milan Gupta et al). 
Metabolic Syndrome 
 In our study using IDF criteria 71.2% our cases had metabolic 
syndrome. Using ATP III criteria 66.3% had metabolic syndrome this 
shows that there is a significant association between metabolic syndrome 
and coronary artery disease. 
 Gupta et al7 says  that metabolic syndrome face a 2 fold greater risk 
of all cause mortality and 2-3 fold increased risk of cardiovascular 
mortality compared to those without this syndrome. 
 Solymoss BC, Bourass MG, Lesporance J.et al. in the study 
“Incidence and clinical characteristics of the metabolic syndrome in 
patients with  coronary artery disease” Coronary artery disease 2003;38 
in a Canadian population with CAD (793 men  315 women of age 58.1 
+9.8 years) noted that metabolic syndrome patients had significantly 
higher waist circumference, blood pressure levels and low level of HDL 
levels. In their study 51% of participants had metabolic syndrome (using 
NCEP, ATP III Criteria) 
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 In our study using ATP III criteria the percentage of MS was 66.3% 
showing a high prevalence of metabolic syndrome in our population. 
 In our study we could detect more cases of MS by IDF criteria than 
by ATP III criteria Chee – Eng Tan, Stefan MG, Doniel wan et al – in the 
study “Can we apply the NCEP – ATP III Definition of the metabolic 
syndrome to Asians?”39 diabetes care 2004, says that decreasing waist 
circumference cut of value from 88cm to 80 cm increased the crude 
prevalence of metabolic syndrome from 12.2 to 17.9%. Using modified 
Asian criteria the prevalence of metabolic syndrome increased 31.0% in 
those aged 60-69 years. 
 Their conclusion is NCEP – ATP III criteria applied to Asian 
population  will under estimate the population at  risk. With a lower waist 
circumference cut off, the prevalence of metabolic syndrome is 
comparable to that in western populations. Ethnic differences are likely to 
exist between populations across Asia. 
 Milan Gupta et al says when ATP III criteria and modified waist 
circumference cut off were used, the metabolic syndrome was present in 
41.1% of urban Indian adults and in 27.9% of subjects with normal 
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plasma glucose.  Our study result is comparable to this. In our study 25% 
of the control (with normal plasma glucose) had metabolic syndrome. 
 Deepa M; Farooq S, Datta S, et al in study “Prevalence of 
metabolic syndrome using WHO , ATP III and IDF Definitions in 
Asian Indians; the Chennai urban Rural Epidemology study (CURES 
-34)40 Feb – 2007. 
 This is one of the largest epidemiological study on diabetes carried 
out in India. In which 26000, individuals >20 years were screened for 
metabolic syndrome. Metabolic syndrome  was identified in 23.2 % cases 
by WHO criteria, 18.3% by ATP III criteria and 25.8 by IDF criteria. 
There was an increased risk of probable CAD in metabolic syndrome 
subjects diagnosed by WHO criteria. They concludes that in Asian 
Indians, the WHO, ATP III  and IDF criteria identify MS differently. 
 DECODA study group41 in the study “Prevalence of metabolic 
syndrome  in populations of Asian origin, comparison of the IDF 
definition with the NCEP definition,” they found that the IDF brought  
out a higher prevalence of the MS than NCEP in all groups (Chinese, 
Mauritian Indians and native Indians) except for Japanese women. 
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SUMMARY 
              The study “Waist circumference as a significant risk factor for 
coronary artery disease in females’’ was a case control study with 80 
female patients admitted with acute myocardial infarction, in Govt. Rajaji 
hospital, Madurai. Controls were devoid of hypertension, diabetes and 
coronary artery disease. 
               Patients and controls who satisfied the inclusion criteria 
underwent various investigations like blood sugar, urea, creatinine, lipid 
profile, ECG & echocardiogram. Relationship of various anthropometric 
measurements like waist circumference, waist hip ratio and body mass 
index with the risk factors of coronary artery disease were analyzed. A 
high waist circumference had an important correlation with hypertension, 
diabetes, dyslipidemia and metabolic syndrome. Females with coronary 
artery disease were detected to have a high prevalence of metabolic 
syndrome.  
Thus our study highlights the significance of a simple measurement 
of waist circumference in day to-day clinical practice in detecting the 
patients with high cardiovascular risk like hypertension, diabetes, obesity, 
dyslipidemia and metabolic syndrome. The cut off values for waist 
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circumference, waist hip ratio and BMI should be defined according to the 
different ethnic populations. This will help in early detection of the people 
at risk so that we can advice healthy life style and nutritional habits for the 
high risk group and start specific therapy when ever necessary. 
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CONCLUSION 
 
 The following conclusions are derived from our study.  
1. Waist circumference ≥80cm is an important risk factor for coronary 
artery disease in females.  
2. In females, cut off value of waist circumference ≥80cm (instead of 
≥88cm) is more sensitive in detecting coronary artery disease risk 
factors. 
3. Waist Circumference ≥80cm is a better parameter than WHR≥ 0.85 
for detection of coronary artery disease risk factors in females.  
4. In females cut off value of BMI as ≥23kg/m2 instead of ≥25kg/m2 
is more sensitive in detecting coronary artery disease risk factors.  
5. Waist circumference >80cm has significant correlation with 
elevated triglycerides, total cholesterol, LDL, and TC/HDL ratio 
(maximum correlation with increased triglyceride). 
6. Waist circumference >80cm has a significant correlation with 
hypertension, diabetes, obesity and metabolic syndrome. 
7. There is a significantly high prevalence of metabolic syndrome 
among the females with Coronary artery disease. 
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PROFORMA 
WAIST CIRCUMFERENCE  
AS A SIGNIFICANT CORONARY RISK FACTORS FOR 
FEMALES 
1. Sl.No   :     
2. Name   :      
3. IP/OP No  : 
4. Age   :   
5. Domicile   : Urban /Rural 
6. Employed   : Yes / No  
7. Life Style  : Sedentary / Non Sedentary 
8. Diet   : Vegetarian / Non Veg. 
9. Addiction  :  Tobacco abuse / Any others 
10.  Personality type : Type A / Type B 
11. Menstrual Status : Pre menopausal / Post menopausal 
12. Admitted for C/o : Chest pain / Dyspnea / Giddiness /  
Pedal edema / Palpitation / Others 
13. Past History  : HT / DM / CVA / CAD / Others 
14. Drug History : OCP / Steroids / Beta blocker / 
 Frusemide / Others. 
15. Family H/o CAD : Yes / No 
16. Examination :  Anthropometry 
Height 
(in cm) 
Weight 
(in kgs) 
BMI 
Kg/m2 
Waist (in cm) 
Circumference 
Hip (in cm) 
Circumference
W/H 
Ratio 
      
  
 G.E.    : Pallor /Edema /Cyanosis / Jaundice /Clubbing 
 CVS   : PR :  BP  :  JVP: 
    S1  S2  S3  S4 
 RS  :  
 Abdomen  :   
17. Investigation  :  
FBS PPBS Bl.Urea S.Creatinine Hb 
     
    Lipid Profile  : 
 
ECG   : 
 
ECHO  : 
Total 
cholesterol 
T.G. HDL VLDL LDL 
     
DESIRABLE WEIGHTS OF ADULTS ACCORDING TO 
BODY MASSS INDEX  
 
 
 
 
A- ABDOMINAL OBESITY (APPLE SHAPE)  
 
 
B- GENERALISED OBESITY (PEAR SHAPE)  
 
 
 
 
 
 
 
 
ADIPOCYTOKINES 
 
 
 
 
 
OVERPRODUCTION OF ADIPOSE TISSUE DERIVED 
PROTEOHORMONES IN OBESITY PROMOTES THE 
DEVELOPMENT OF METABOLIC SYNDROME 
 
 
 
 
All fat cells are not created equal  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Large insulin   
   resistant       
   Adipocyte  
 
• Increased  
   cytokine  
   production  
 
• Increased   
   release of  
   FFAs 
 
• Site of  
  adiponectin  
  production  
 
• Small Insulin  
  Sensitive  
  Adipocytes  
 
•Little    endocrine  
  activity  
 
  
 
ATHEROGENIC  DYSLIPIDEMIA  
 
 
 
Relationship between visceral fat and the development of 
“atherogenic dyslipidemia” characterized by  
1) An increase in small, dense LDL particles    
2) Elevated levels of VLDL, triglycerides    
3) Low levels of HDL- cholesterol.   
  
 
PATHOGENESIS OF METABOLIC SYNDROME 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
BMI AND WEIGHT CUT POINT FOR OVERWEIGHT AND 
OBSEITY AT DIFFEENT HEIGHTS IN ASIAN INDIANS 
 
Optimum  Overweight Obsese1 Obese 2  BMI 
20 23 25 30 
Height in cm Weight in kg  
146 43 49 53 64 
149 44 51 56 67 
152 46 53 58 69 
155 48 55 60 72 
158 50 57 62 75 
161 52 60 65 78 
164 54 62 67 81 
167 56 64 70 84 
170 58 66 72 87 
173 60 69 75 90 
176 62 71 77 93 
179 64 74 80 96 
182 66 76 83 99 
185 68 79 86 103 
188 71 81 88 106 
191 73 84 91 109 
194 75 87 94 113 
197 78 89 97 116 
200 80 92 100 120 
 
 
Adapted from NHLBI obesity Task Force, 199859 & 
diabetes.com.au/research_obesity.htm Feb 200060 
KEY TO MASTER CHART 
T   -  Test  
C    -  Control 
      1   2 
1. Domicile     Urban   Rural 
2. Employed     Yes    No  
3.  Socioeconomic status   High    Low  
4.  Life style     Sedentary   Non sedentary 
5. Diet      Vegetarian  Non vegetarian   
6. Tobacco smoking    Present   Absent  
7. Personality type   A   B 
8.  Menstrual status    Premenopausal  Postmenopausal  
9. HT     Present  Absent  
10.  DM      Present  Absent    
11.  CVA      Present  Absent   
12.  OCP use     Present  Absent   
13. Family History   Present  Absent   
14.  MS1 (IDF)    Present  Absent   
15. MS2 (ATP III)   Present  Absent   
 
HT  - Hypertension  
DM  - Diabetes Mellitus  
CVA   - Cerebrovascular Accident  
OCP  - Oral Contraceptive Pill 
F/H   - Family History  
Ht  - Height  
Wt  - Weight 
BMI  - Body Mass Index  
W.C  - Wasit Circumference  
H.C  - Hip Circumference  
W/H  - Waist Hip Ratio 
B.P  - Blood Pressure  
FBS  - Fasting Blood Sugar  
PPBS  - Post Prandial Blood Sugar  
TC  - Total Cholesterol  
TGL  - Triglyceride  
HDL  - High Density Lipoprotein  
VLDL - Very High Density Lipoprotein  
LDL  - Low  Density Lipoprotein 
EF  - Ejection Fraction  
MS1  - Metabolic Syndrome (IDF) 
MS2  - Metabolic Syndrome (ATP III) 
